Answers are grounded in this paper and cite their sources.
Blood cancers, including leukemia, lymphoma, and myeloma, represent a significant burden on global health [1,2].In 2020, hematologic malignancies represented approximately 6.2% of all new cancer diagnoses globally, with an estimated 474,519 cases of leukemia (2.5%), 544,352 cases of non-Hodgkin lymphoma (2.8%), and 176,404 cases of multiple myeloma (0.9%) [2].While substantial advancements have been made in understanding and treating these diseases, disparities in health service use and self-management experiences between ethnic groups remain a prominent concern, particularly among South Asians."South Asian" refers to individuals of Bangladeshi, Indian, Indo-Caribbean, Pakistani, Sri Lankan, Nepali, Bhutanese, and Maldivian descent [3,4].Although unified by geographic origin, South Asians represent a diverse population with variations in the languages they speak, the religions they practice, and the sociocultural norms they hold [5].Given their unique sociocultural context, they also experience barriers to healthcare access, such as language barriers, stigma, cultural and religious beliefs, and gender roles.Therefore, investigating
No takes yet. Share an insight, caveat, or question.
Dhillon et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: